Pattern of care and post-progression survival in recurrent GBM after TMZ-based chemoradiation

被引：0
|
作者：
Kim, D. [1 ,2 ]
Lee, J. H. [2 ,3 ]
Yoon, H. I. [4 ]
Kim, N. [5 ]
Lim, D. H. [5 ]
Song, J. H. [6 ]
Wee, C. W. [3 ,7 ]
Kim, I. A. [3 ,8 ]
机构：
[1] Seoul Natl Univ, Coll Med, Radiat Oncol, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Radiat Oncol, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Radiat Oncol, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Radiat Oncol, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[6] Catholic Univ, Seoul St Marys Hosp, Coll Med, Radiat Oncol, Seoul, South Korea
[7] SMG SNU Boramae Med Ctr, Radiat Oncol, Seoul, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Radiat Oncol, Seongnam, South Korea
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1128
引用
收藏
页码：S902 / S902
页数：1
相关论文
共 42 条
  • [21] Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy
    Imai, Hisao
    Kobayashi, Daijiro
    Kaira, Kyoichi
    Kawashima, Sayaka
    Masubuchi, Ken
    Murata, Masumi
    Ebara, Takeshi
    Kitamoto, Yoshizumi
    Minato, Koichi
    RADIOLOGY AND ONCOLOGY, 2022, 56 (02) : 228 - 237
  • [22] Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study
    Yano, Yukihiro
    Kurebe, Hiroyuki
    Edahiro, Ryuya
    Hosono, Yuki
    Nakatsubo, Saeko
    Nishida, Kohei
    Sawa, Nobuyuki
    Ishijima, Mikako
    Uenami, Takeshi
    Kanazu, Masaki
    Akazawa, Yuki
    Yamaguchi, Toshihiko
    Mori, Masahide
    PLOS ONE, 2018, 13 (08):
  • [23] Continuation of adjuvant temozolomide until tumor progression after upfront chemoradiation therapy produces promising survival in patients with GBM, especially with pseudoprogression.
    Gahramanov, Seymur
    Tyson, Rose Marie
    Lacy, Cynthia
    Netto, Joao Prola
    Nasseri, Morad
    Fu, Rochelle
    Giles, Stephen
    White, Tricia
    Neuwelt, Edward A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Kogure, Yoshihito
    Saka, Hideo
    Oki, Masahide
    Saito, Toshiki I.
    Ahmed, Shimaa Nour Moursi
    Kitagawa, Chiyoe
    Imaizumi, Kazuyoshi
    PLOS ONE, 2015, 10 (08):
  • [25] The Predictive Factors for Post-Progression Survival after EGFR-TKI Failure in Advanced EGFR-Mutant Lung Cancer Patients
    Ebisudani, Toshiki
    Nakashima, Kei
    Misawa, Masafumi
    Tokumoto, Akiko
    Nemoto, Masahiro
    Tsuzuki, Ryuta
    Suzuki, Fumi
    Yamawaki, Satoshi
    Otsuki, Ayumu
    Noma, Satoshi
    Aoshima, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1208 - S1209
  • [26] Deepness of response: A quantitative analysis of its impact on post-progression survival time after first-line treatment in patients with mCRC
    Mansmann, Ulrich Robert
    Sartorius, Ute
    Laubender, Ruediger Paul
    Giessen, Clemens Albrecht
    Esser, Regina
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [27] How Long Have I Got? Estimating Post-Progression Survival after First Line Chemotherapy for Metastatic Breast Cancer Based on Data from Randomized Trials
    Kiely, B. E.
    Lee, C. K.
    Tattersall, M. H. N.
    Stockier, M. R.
    CANCER RESEARCH, 2010, 70
  • [28] The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
    Kondo, Eiji
    Tabata, Tsutomu
    Suzuki, Nao
    Aoki, Daisuke
    Yahata, Hideaki
    Kotera, Yoshio
    Tokuyama, Osamu
    Fujiwara, Keiichi
    Kimura, Eizo
    Terauchi, Fumitoshi
    Sumi, Toshiyuki
    Okamoto, Aikou
    Yaegashi, Nobuo
    Enomoto, Takayuki
    Sugiyama, Toru
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (06) : 1 - 12
  • [29] Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival
    Masubuchi, Ken
    Imai, Hisao
    Wasamoto, Satoshi
    Tsuda, Takeshi
    Minemura, Hiroyuki
    Nagai, Yoshiaki
    Yamada, Yutaka
    Kishikawa, Takayuki
    Umeda, Yukihiro
    Shiono, Ayako
    Takechi, Hiroki
    Shiihara, Jun
    Kaira, Kyoichi
    Kanazawa, Kenya
    Taniguchi, Hirokazu
    Kaburagi, Takayuki
    Kagamu, Hiroshi
    Minato, Koichi
    THORACIC CANCER, 2022, 13 (19) : 2776 - 2785
  • [30] Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
    Kasahara, Norimitsu
    Imai, Hisao
    Kaira, Kyoichi
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Harada, Hideyuki
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamada, Masanobu
    Takahashi, Toshiaki
    RADIOLOGY AND ONCOLOGY, 2015, 49 (04) : 409 - 415
12345